The National PERT Consortium™ is proud to be part of the HI-PEITHO clinical trial in collaboration with Boston Scientific Corporation and the University Medical Center of the Johannes Gutenberg University of Mainz, Germany. HI-PEITHO will compare the use of the EkoSonic™ Endovascular System (EKOS) in combination with anticoagulation to anticoagulation alone for the treatment of acute, intermediate-high-risk pulmonary embolism (PE). The trial will assess whether treatment with EKOS in combination with anticoagulation is associated with a significant reduction in adverse events compared to anticoagulation alone.

Enrollment began in August 2021 and is expected to complete in 2025.

A total of 544 patients will be randomized at 65 institutions across the United States and Europe. 

Learn more here: